200 related articles for article (PubMed ID: 36604358)
41. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.
Hanke K; Brückner CS; Dähnrich C; Huscher D; Komorowski L; Meyer W; Janssen A; Backhaus M; Becker M; Kill A; Egerer K; Burmester GR; Hiepe F; Schlumberger W; Riemekasten G
Arthritis Res Ther; 2009; 11(1):R22. PubMed ID: 19220911
[TBL] [Abstract][Full Text] [Related]
42. Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis.
Volpe A; Ruzzenente O; Caramaschi P; Pieropan S; Tinazzi I; Carletto A; Bambara LM; Biasi D
Rheumatol Int; 2009 Jul; 29(9):1073-9. PubMed ID: 19194705
[TBL] [Abstract][Full Text] [Related]
43. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
44. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
45. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
[TBL] [Abstract][Full Text] [Related]
46. Clinical and autoantibody profiles of systemic sclerosis patients: A cross-sectional study from North India.
Ghosh S; Tanna D; Telang K; Dhuria S; Gupta R
Indian J Dermatol Venereol Leprol; 2023 Jul; ():1-7. PubMed ID: 37436007
[TBL] [Abstract][Full Text] [Related]
47. Autoantibody profiles delineate distinct subsets of scleromyositis.
Leclair V; D'Aoust J; Gyger G; Landon-Cardinal O; Meyer A; O'Ferrall E; Karamchandani J; Massie R; Ellezam B; Satoh M; Troyanov Y; Fritzler MJ; Hudson M;
Rheumatology (Oxford); 2022 Mar; 61(3):1148-1157. PubMed ID: 34146090
[TBL] [Abstract][Full Text] [Related]
48. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
Markusse IM; Meijs J; de Boer B; Bakker JA; Schippers HPC; Schouffoer AA; Ajmone Marsan N; Kroft LJM; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
Rheumatology (Oxford); 2017 Jul; 56(7):1081-1088. PubMed ID: 27940596
[TBL] [Abstract][Full Text] [Related]
49. Autoantibody profile and clinical correlation in a group of patients with systemic sclerosis in southern Brazil.
Müller Cde S; Paiva Edos S; Azevedo VF; Radominski SC; Lima Filho JH
Rev Bras Reumatol; 2011; 51(4):314-8, 323-4. PubMed ID: 21779708
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
Hudson M; Pope J; Mahler M; Tatibouet S; Steele R; Baron M; ; Fritzler MJ
Arthritis Res Ther; 2012 Mar; 14(2):R50. PubMed ID: 22394602
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca Complaints.
Marketos N; Mavragani CP
Mediterr J Rheumatol; 2023 Sep; 34(3):398-402. PubMed ID: 37941855
[TBL] [Abstract][Full Text] [Related]
52. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
[TBL] [Abstract][Full Text] [Related]
53. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.
Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F;
Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611
[TBL] [Abstract][Full Text] [Related]
54. Case Report: Systemic Sclerosis After Covid-19 Infection.
Fineschi S
Front Immunol; 2021; 12():686699. PubMed ID: 34262566
[TBL] [Abstract][Full Text] [Related]
55. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of anti-NOR90 antibodies in systemic sclerosis and idiopathic interstitial pneumonia.
Yamashita Y; Yamano Y; Muro Y; Ogawa-Momohara M; Takeichi T; Kondoh Y; Akiyama M
Rheumatology (Oxford); 2022 Apr; 61(4):1709-1716. PubMed ID: 34282441
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
[TBL] [Abstract][Full Text] [Related]
58. Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.
Temiz Karadağ D; Komac A; Erez Y; Birlik AM; Sari A; Akdoğan A; Farisogullari B; Kimyon G; Koc E; Arslan D; Karatas A; Koca SS; Kasifoglu N; Yazici A; Hayran KM; Cefle A
Immun Inflamm Dis; 2023 Dec; 11(12):e1089. PubMed ID: 38134320
[TBL] [Abstract][Full Text] [Related]
59. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
[TBL] [Abstract][Full Text] [Related]
60. Ethnic Differences in Autoantibody Diversity and Hierarchy: More Clues from a US Cohort of Patients with Systemic Sclerosis.
Nandiwada SL; Peterson LK; Mayes MD; Jaskowski TD; Malmberg E; Assassi S; Satoh M; Tebo AE
J Rheumatol; 2016 Oct; 43(10):1816-1824. PubMed ID: 27481902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]